Retailers could know on Monday whether an attempt to abolish resale price maintenance on over-the-counter medicines must go back to square one. The OFT inquiry was halted last month because a member of the Restrictive Practices Court panel had a conflict of interest. The OFT meets on Monday to decide whether it is possible to continue the case or start afresh. {{NEWS }}